Cargando…

A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex

BACKGROUND: Tuberous sclerosis complex (TSC) is a rare multisystem disorder caused by mutations in the TSC1 or TSC2 gene. More than 90% of patients with TSC develop neurological and/or neuropsychiatric manifestations. The aim of the present study was to determine the developmental and cognitive long...

Descripción completa

Detalles Bibliográficos
Autores principales: Mammadova, D., Vecko, J., Hofmann, M., Schüssler, S. C., Deiters, L., Canda, A., Wieland, A. K., Gollwitzer, S., Hamer, H., Trollmann, Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637019/
https://www.ncbi.nlm.nih.gov/pubmed/37946245
http://dx.doi.org/10.1186/s13023-023-02959-0
_version_ 1785133319494565888
author Mammadova, D.
Vecko, J.
Hofmann, M.
Schüssler, S. C.
Deiters, L.
Canda, A.
Wieland, A. K.
Gollwitzer, S.
Hamer, H.
Trollmann, Regina
author_facet Mammadova, D.
Vecko, J.
Hofmann, M.
Schüssler, S. C.
Deiters, L.
Canda, A.
Wieland, A. K.
Gollwitzer, S.
Hamer, H.
Trollmann, Regina
author_sort Mammadova, D.
collection PubMed
description BACKGROUND: Tuberous sclerosis complex (TSC) is a rare multisystem disorder caused by mutations in the TSC1 or TSC2 gene. More than 90% of patients with TSC develop neurological and/or neuropsychiatric manifestations. The aim of the present study was to determine the developmental and cognitive long-term outcomes of pediatric TSC patients. METHODS: This cross-sectional, monocenter study included pediatric TSC patients who received multidisciplinary long-term care with a last visit between 2005 and 2019. Neurological manifestations and cognitive development (BSID, K-ABC) were analyzed in relation to age and type of mutation. RESULTS: Thirty-five patients aged 13.5 ± 7.8 years were included in the study. Diagnosis was confirmed genetically in 65.7% of patients (TSC1, 26.1%; TSC2, 65.2%; NMI, 8.7%). Mean age at diagnosis was 1.3 ± 3.5 years; 74.3% of the patients had been diagnosed within the first year of life due to seizures (62.9%) or/and cardiac rhabdomyomas (28.6%). The most common TSC manifestations included structural brain lesions (cortical tubers, 91.4%; subependymal nodules, 82.9%), epilepsy (85.7%), and cardiac rhabdomyomas (62.9%). Mean age at seizure onset was 1.5 ± 2.3 years, with onset in 80.0% of patients within the first two years of life. Infantile spasms, which were the first seizure type in 23.3% of the patients, developed earlier (0.6 ± 0.4 years) than focal seizures (1.8 ± 2.5 years). Refractory epilepsy was present in 21 (70.0%) patients, mild or severe intellectual impairment in 66.6%, and autism spectrum disorders in 11.4%. Severe cognitive impairment (33.3%) was significantly associated with epilepsy type and age at seizure onset (p < 0.05). CONCLUSIONS: The results emphasized the phenotypic variability of pediatric-onset TSC and the high rate of neurological and neuropsychiatric morbidity. Early-onset refractory epilepsy was associated with impaired cognitive development. Children of all ages with TSC require multidisciplinary long-term care and individual early-intervention programs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02959-0.
format Online
Article
Text
id pubmed-10637019
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106370192023-11-11 A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex Mammadova, D. Vecko, J. Hofmann, M. Schüssler, S. C. Deiters, L. Canda, A. Wieland, A. K. Gollwitzer, S. Hamer, H. Trollmann, Regina Orphanet J Rare Dis Research BACKGROUND: Tuberous sclerosis complex (TSC) is a rare multisystem disorder caused by mutations in the TSC1 or TSC2 gene. More than 90% of patients with TSC develop neurological and/or neuropsychiatric manifestations. The aim of the present study was to determine the developmental and cognitive long-term outcomes of pediatric TSC patients. METHODS: This cross-sectional, monocenter study included pediatric TSC patients who received multidisciplinary long-term care with a last visit between 2005 and 2019. Neurological manifestations and cognitive development (BSID, K-ABC) were analyzed in relation to age and type of mutation. RESULTS: Thirty-five patients aged 13.5 ± 7.8 years were included in the study. Diagnosis was confirmed genetically in 65.7% of patients (TSC1, 26.1%; TSC2, 65.2%; NMI, 8.7%). Mean age at diagnosis was 1.3 ± 3.5 years; 74.3% of the patients had been diagnosed within the first year of life due to seizures (62.9%) or/and cardiac rhabdomyomas (28.6%). The most common TSC manifestations included structural brain lesions (cortical tubers, 91.4%; subependymal nodules, 82.9%), epilepsy (85.7%), and cardiac rhabdomyomas (62.9%). Mean age at seizure onset was 1.5 ± 2.3 years, with onset in 80.0% of patients within the first two years of life. Infantile spasms, which were the first seizure type in 23.3% of the patients, developed earlier (0.6 ± 0.4 years) than focal seizures (1.8 ± 2.5 years). Refractory epilepsy was present in 21 (70.0%) patients, mild or severe intellectual impairment in 66.6%, and autism spectrum disorders in 11.4%. Severe cognitive impairment (33.3%) was significantly associated with epilepsy type and age at seizure onset (p < 0.05). CONCLUSIONS: The results emphasized the phenotypic variability of pediatric-onset TSC and the high rate of neurological and neuropsychiatric morbidity. Early-onset refractory epilepsy was associated with impaired cognitive development. Children of all ages with TSC require multidisciplinary long-term care and individual early-intervention programs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02959-0. BioMed Central 2023-11-09 /pmc/articles/PMC10637019/ /pubmed/37946245 http://dx.doi.org/10.1186/s13023-023-02959-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mammadova, D.
Vecko, J.
Hofmann, M.
Schüssler, S. C.
Deiters, L.
Canda, A.
Wieland, A. K.
Gollwitzer, S.
Hamer, H.
Trollmann, Regina
A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex
title A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex
title_full A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex
title_fullStr A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex
title_full_unstemmed A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex
title_short A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex
title_sort single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637019/
https://www.ncbi.nlm.nih.gov/pubmed/37946245
http://dx.doi.org/10.1186/s13023-023-02959-0
work_keys_str_mv AT mammadovad asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT veckoj asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT hofmannm asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT schusslersc asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT deitersl asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT candaa asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT wielandak asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT gollwitzers asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT hamerh asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT trollmannregina asinglecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT mammadovad singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT veckoj singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT hofmannm singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT schusslersc singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT deitersl singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT candaa singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT wielandak singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT gollwitzers singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT hamerh singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex
AT trollmannregina singlecenterobservationalstudyonlongtermneurodevelopmentaloutcomesinchildrenwithtuberoussclerosiscomplex